Treatment of xeroderma pigmentosum variant with low-dose etretinate.
Finkelstein
E
E
Lazarov
A
A
Halevy
S
S
D005050:Etretinate / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007641:Keratolytic Agents / Q000627:therapeutic use*; D008875:Middle Aged; D012878:Skin Neoplasms / Q000188:drug therapy*; D014983:Xeroderma Pigmentosum / Q000188:drug therapy*
D007641:Keratolytic Agents; D005050:Etretinate